Main Article Content
Abstract
Keywords
Article Details
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Agarwal MB (2009). Advances in management thalas-semia. Indian Journal of Pediatrics 76, 177-184
- Aydinok Y, Ulger Z, Nart D, Terzi A, Cetiner N, Ellis G, Zimmermann A, Manz C (2007). A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Haematologica 92, 1599-1606
- Ganie RA (2005). Thalassemia: permasalahan dan penanganannya. Pidato Pengukuhan Jabatan Guru Besar Tetap dalam Bidang Ilmu Patologi pada Fakultas Kedokteran, Universitas Sumatera Utara, Presented in Medan November 16, 2005
- Olivieri NF and Weatherall DJ (2006). Thalassemias. In: Arceci RJ, Hann IM, Smith OP, Hoffbrand AV (eds). Pediatric Hematology 3rd Ed, Massachusetts, Blackwell Publishing, p 281-305
- Priyatinigsih DR (2010). Pengaruh deferasirox terhadap kadar T4 dan TSH pada penderita ï¢-Thalassemia Mayor dengan feritin yang tinggi. Thesis. Universitas Diponegoro, Semarang
- Ruswandi (2009). Jumlah penderita thalassemia naik 8,3%. Available from http://kesehatan.kompas.com/ read/2009/03/05/21122544/Jumlah.Penderita.Thalassemia.Naik.8.3.Persen. Accessed March 5, 2009
- Turgeon ML (2011). Clinical Hematology Theory and Procedures 5th ed, Philadephia, Lippincott Williams & Wilkins, p 220-223
- Won SC, Han DK, Seo JJ, Chung NG, Park SK, Park KB, Kook H, Lyu CJ (2010). Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients. Korean J Hematol 45, 58-61
References
Agarwal MB (2009). Advances in management thalas-semia. Indian Journal of Pediatrics 76, 177-184
Aydinok Y, Ulger Z, Nart D, Terzi A, Cetiner N, Ellis G, Zimmermann A, Manz C (2007). A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Haematologica 92, 1599-1606
Ganie RA (2005). Thalassemia: permasalahan dan penanganannya. Pidato Pengukuhan Jabatan Guru Besar Tetap dalam Bidang Ilmu Patologi pada Fakultas Kedokteran, Universitas Sumatera Utara, Presented in Medan November 16, 2005
Olivieri NF and Weatherall DJ (2006). Thalassemias. In: Arceci RJ, Hann IM, Smith OP, Hoffbrand AV (eds). Pediatric Hematology 3rd Ed, Massachusetts, Blackwell Publishing, p 281-305
Priyatinigsih DR (2010). Pengaruh deferasirox terhadap kadar T4 dan TSH pada penderita ï¢-Thalassemia Mayor dengan feritin yang tinggi. Thesis. Universitas Diponegoro, Semarang
Ruswandi (2009). Jumlah penderita thalassemia naik 8,3%. Available from http://kesehatan.kompas.com/ read/2009/03/05/21122544/Jumlah.Penderita.Thalassemia.Naik.8.3.Persen. Accessed March 5, 2009
Turgeon ML (2011). Clinical Hematology Theory and Procedures 5th ed, Philadephia, Lippincott Williams & Wilkins, p 220-223
Won SC, Han DK, Seo JJ, Chung NG, Park SK, Park KB, Kook H, Lyu CJ (2010). Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients. Korean J Hematol 45, 58-61